Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Everolimus plus tamoxifen delays disease progression in HR+/HER2- metastatic breast cancer

Aromatase inhibitors raise risk of cardiovascular disease in postmenopausal breast cancer patients

Aromatase inhibitors raise risk of cardiovascular disease in postmenopausal breast cancer patients

Breast cancer patients more likely to have joint pain from taking AIs: Study

Breast cancer patients more likely to have joint pain from taking AIs: Study

Special Surgery investigators to present future of clinical care at ACR annual meeting

Special Surgery investigators to present future of clinical care at ACR annual meeting

Aromatase inhibitors increase side effects in women undergoing breast cancer therapy

Aromatase inhibitors increase side effects in women undergoing breast cancer therapy

Joint complaints attributed to breast cancer drugs not linked with inflammatory arthritis or autoimmune disease

Joint complaints attributed to breast cancer drugs not linked with inflammatory arthritis or autoimmune disease

Amgen wins Scrip Best New Drug award for Prolia

Amgen wins Scrip Best New Drug award for Prolia

New radiotracer application may advance understanding of estrogen-related diseases

New radiotracer application may advance understanding of estrogen-related diseases

Researchers find genetic variants that cause arthritis in breast cancer patients taking aromatase inhibitors

Researchers find genetic variants that cause arthritis in breast cancer patients taking aromatase inhibitors

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

SRI and Taiho collaborate to advance clinical development of TAS-108 breast cancer program

SRI and Taiho collaborate to advance clinical development of TAS-108 breast cancer program

Merrimack, sanofi-aventis initiate dosing in MM-121 and exemestane combination Phase 2 breast cancer study

Merrimack, sanofi-aventis initiate dosing in MM-121 and exemestane combination Phase 2 breast cancer study

Roxane announces FDA approval for Anastrozole Tablets ANDA

Roxane announces FDA approval for Anastrozole Tablets ANDA

New guideline to improve IHC testing for expression status of ER and PgR in breast cancer issued

New guideline to improve IHC testing for expression status of ER and PgR in breast cancer issued

Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 2010

Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 2010

Study provides personalized strategies to boost AIAA compliance in breast cancer patients

Study provides personalized strategies to boost AIAA compliance in breast cancer patients

Genes influence AIAA side effect in breast cancer survivors

Genes influence AIAA side effect in breast cancer survivors

Amgen announces European approval of Prolia

Amgen announces European approval of Prolia

Genome sequencing of tumors biopsied from women with invasive breast cancer

Genome sequencing of tumors biopsied from women with invasive breast cancer

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment